Northwest Biotherapeutics (OTCMKTS:NWBO) Share Price Crosses Above Fifty Day Moving Average – Here’s What Happened

Shares of Northwest Biotherapeutics, Inc. (OTCMKTS:NWBO) crossed above its 50 day moving average during trading on Monday . The stock has a 50 day moving average of $0.26 and traded as high as $0.2636. Northwest Biotherapeutics shares last traded at $0.2592, with a volume of 1,867,648 shares trading hands.

Northwest Biotherapeutics Price Performance

The stock has a market capitalization of $412.19 million, a P/E ratio of -0.01 and a beta of -0.86. The company’s 50 day simple moving average is $0.26 and its two-hundred day simple moving average is $0.25.

Northwest Biotherapeutics (OTCMKTS:NWBO) last announced its earnings results on Friday, November 14th. The biotechnology company reported ($18.22) EPS for the quarter. The firm had revenue of $0.20 million during the quarter.

About Northwest Biotherapeutics

Northwest Biotherapeutics, Inc is a clinical-stage biotechnology company focused on the development of personalized dendritic cell immunotherapies for the treatment of cancer. The company’s proprietary platform harnesses patient-derived dendritic cells to present tumor-specific antigens and stimulate a targeted immune response. By tailoring each vaccine to the individual patient’s tumor profile, the approach aims to improve outcomes and reduce off-target toxicity associated with conventional therapies.

The company’s lead candidate, DCVax®-L, is designed for patients with newly diagnosed or recurrent glioblastoma multiforme (GBM) and has advanced through a global Phase III clinical trial.